title: Cholinergic modulation of neural activity in the telencephalon of the zebrafish.
abstract: In this study, we have assessed the effects of muscarinic receptor activation on neural activity in the telencephalon of the zebrafish. Electrically evoked field potentials via the stimulation of the posterior dorsal telencephalon were recorded in the anterior dorsal telencephalon of the ipsilateral hemisphere, with a peak latency of 20-30ms. The application of carbachol (1-25microM) and oxotremorine-M (0.25-60microM) suppressed the amplitude of field potentials in a dose-dependent manner. This suppressive effect was blocked by a muscarinic receptor antagonist, atropine (20microM), and an M1 receptor antagonist, pirenzepine (5microM), but not by the M2 receptor antagonists, methoctramine (5microM) and gallamine (5microM). Oxotremorine-M (1microM) also suppressed the induction of field potentials via the stimulation of the contralateral telencephalon and the medial fiber bundle, which was blocked by atropine (20microM). An acetylcholine esterase inhibitor, physostigmine (20-30microM), reduced the peak amplitude of the evoked field potentials, while increasing late bursting activity. Furthermore, a high dose of physostigmine (100microM) induced spontaneous bursting activity. These results demonstrated the cholinergic influence on the neural activity in the telencephalon of the zebrafish.
authors.affiliation: Department of Biological Sciences, Inha University, 253 Younghyun-Dong, Nam-Gu, Inchon 402-751, Republic of Korea.
authors.forename: Eunjin
authors.initials: E
authors.lastname: Park
authors.forename: Yunkyung
authors.initials: Y
authors.lastname: Lee
authors.forename: Yongjung
authors.initials: Y
authors.lastname: Kim
authors.forename: Chang-Joong
authors.initials: CJ
authors.lastname: Lee
mesh_terms: D000109:Acetylcholine / Q000378:metabolism*; D000704:Analysis of Variance; D000818:Animals; D018678:Cholinergic Agents / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation / Q000379:methods; D005071:Evoked Potentials / Q000502:physiology / Q000528:radiation effects; D007839:Functional Laterality; D066298:In Vitro Techniques; D018721:Muscarinic Agonists / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000528:radiation effects; D010095:Oxotremorine / Q000031:analogs & derivatives / Q000494:pharmacology; D018408:Patch-Clamp Techniques / Q000379:methods; D013687:Telencephalon / Q000166:cytology*; D013997:Time Factors; D015027:Zebrafish / Q000033:anatomy & histology
chemical_list: D018678:Cholinergic Agents; D018721:Muscarinic Agonists; D010095:Oxotremorine; C042743:oxotremorine M; D000109:Acetylcholine